Tetra Therapeutics, a SHIONOGI Group Company
Entity

  • Tetra Therapeutics, a SHIONOGI Group Company

    Created in 2010
  • BETA

    Up & running (A)
    Existing signals show a regular activity

  • Social networks

    715

  • Activities

    biotech deeptech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    Soutwest Michigan Innovation Center, 4717 Campus Dr, Kalamazoo, MI 49008, USA

    Kalamazoo

    United States of America

  • Employees

    Scale: 201-500

    Estimated: 6

  • Engaged corporates

    1
    1 0

  • Added in Motherbase

    4 months, 2 weeks ago
Description
  • Value proposition

    Follow us at Shionogi Inc. for news about our rare disease research programs

    https://www.linkedin.com/company/shionogi-inc-/

    drug discovery, PDE4D, PDE4B, Fragile X, CTE, Rubinstein-Taybi, traumatic brain injury, Clinical Trials, Fragile X syndrome, Cognition, BPN14770, and Memory Loss

  • Shionogi Inc. - A Discovery-Based Pharmaceutical Company

    Shionogi Inc. is dedicated to advancing the greater good by developing, partnering, and commercializing medicine to treat serious unmet medical needs.

    • https://www.shionogi.com/us/en/
Corporate interactions BETA
Corporate TypeTweets Articles
Shionogi & Co., Ltd
Shionogi & Co., Ltd
Pharmaceutical
Shionogi & Co., Ltd
Pharmaceutical 		Other

6 Mar 2024


Similar entities
Last news
Show all articles
Social network dynamics